Literature DB >> 19945444

Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice.

Anil Kumar1, Ruchika Garg, Vaibhav Gaur, Puneet Kumar.   

Abstract

Present study has been designed to elucidate the nitric oxide modulatory mechanism of venlafaxine in experimental model of chronic behavior despair in mice. Animals (male albino laca mice) were forced to swim daily for 6 min test session for 7 days and immobility period of each animal was measured on every alternate days. Six minutes forced swimming test session for 7 days caused anxiety-like behavior (as assessed by mirror chamber and plus maze tests) and impairment in locomotor activity followed by oxidative damage (increased lipid peroxidation, nitrite concentration, depleted reduced glutathione and catalase activity) as compared to naïve animals. Seven days venlafaxine (5 and 10 mg/kg) treatment significantly caused anti-anxiety-like effect, improved locomotor activity and attenuated oxidative damage (reduced lipid peroxidation, nitrite concentration and caused restoration of reduce glutathione and catalase activity) as compared to control. Caffeine (10 mg/kg) pretreatment with venlfaxine (5 mg/kg) did not produce any significant effect on locomotor activity, immobility period and oxidative damage as compared to their effect per se. Further, L-NAME (5 mg/kg) and methylene blue (10 mg/kg) pretreatment with sub effective dose of venlafaxine (5 mg/kg) potentiated its protective effect which was significant as compared to their effect per se. However, L-arginine (100 mg/kg) pretreatment with venlafaxine (5 mg/kg) significantly reversed the protective effect of venlafaxine (P<0.05). Present study suggests that nitric oxide modulation might be involved in the protective effects of venlafaxine. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19945444     DOI: 10.1016/j.brainres.2009.11.050

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Neuronal NOS inhibitor and conventional antidepressant drugs attenuate stress-induced fos expression in overlapping brain regions.

Authors:  Michelle Silva; Daniele C Aguiar; Cassiano R A Diniz; Francisco Silveira Guimarães; Sâmia R L Joca
Journal:  Cell Mol Neurobiol       Date:  2011-11-27       Impact factor: 5.046

2.  Effects on enantiomeric drug disposition and open-field behavior after chronic treatment with venlafaxine in the P-glycoprotein knockout mice model.

Authors:  Louise Karlsson; Christoph Hiemke; Björn Carlsson; Martin Josefsson; Johan Ahlner; Finn Bengtsson; Ulrich Schmitt; Fredrik C Kugelberg
Journal:  Psychopharmacology (Berl)       Date:  2010-12-30       Impact factor: 4.530

3.  Venlafaxine inhibits naloxone-precipitated morphine withdrawal symptoms: Role of inflammatory cytokines and nitric oxide.

Authors:  Mohammad Taghi Mansouri; Bahareh Naghizadeh; Behnam Ghorbanzadeh; Neda Amirgholami; Gholamreza Houshmand; Soheila Alboghobeish
Journal:  Metab Brain Dis       Date:  2019-10-19       Impact factor: 3.584

4.  Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction.

Authors:  Vaibhav Gaur; Anil Kumar
Journal:  Inflammopharmacology       Date:  2011-08       Impact factor: 4.473

Review 5.  Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine.

Authors:  Claire Rampon; Bruno P Guiard; Basile Coutens; Antoine Yrondi
Journal:  Psychopharmacology (Berl)       Date:  2022-08-10       Impact factor: 4.415

6.  Increased oxidative stress in patients with depression and its relationship to treatment.

Authors:  Cecilia P Chung; Dennis Schmidt; Charles Michael Stein; Jason D Morrow; Ronald M Salomon
Journal:  Psychiatry Res       Date:  2012-12-11       Impact factor: 3.222

7.  Increased Signaling via Adenosine A1 Receptors, Sleep Deprivation, Imipramine, and Ketamine Inhibit Depressive-like Behavior via Induction of Homer1a.

Authors:  Tsvetan Serchov; Hans-Willi Clement; Martin K Schwarz; Felice Iasevoli; Dilip K Tosh; Marco Idzko; Kenneth A Jacobson; Andrea de Bartolomeis; Claus Normann; Knut Biber; Dietrich van Calker
Journal:  Neuron       Date:  2015-08-05       Impact factor: 17.173

8.  Behavioral and neuronal biochemical possible effects in experimental induced chronic mild stress in male albino rats under the effect of oral barley administration in comparison to venlafaxine.

Authors:  Inas E Darwish; Hala M Maklad; Iman H Diab
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-05-27

9.  Clinical implications of lipid peroxidation in acne vulgaris: old wine in new bottles.

Authors:  Whitney P Bowe; Alan C Logan
Journal:  Lipids Health Dis       Date:  2010-12-09       Impact factor: 3.876

10.  Nitric oxide modulation in protective role of antidepressants against chronic fatigue syndrome in mice.

Authors:  Anil Kumar; Ruchika Garg; Vaibhav Gaur; Puneet Kumar
Journal:  Indian J Pharmacol       Date:  2011-05       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.